Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Activation of C3 via the alternative complement pathway results in fixation of C3b to the pneumococcal cell wall.

× No keyword cloud information.

25 in total

1. Pneumococcal surface protein A inhibits complement activation by Streptococcus pneumoniae.

Authors: A H Tu; R L Fulgham; M A McCrory; D E Briles; A J Szalai
Journal: Infect Immun Date: 1999-09 Impact factor: 3.441

2. Genetic alteration of capsule type but not PspA type affects accessibility of surface-bound complement and surface antigens of Streptococcus pneumoniae.

Authors: Melanie Abeyta; Gail G Hardy; Janet Yother
Journal: Infect Immun Date: 2003-01 Impact factor: 3.441

Review 3. Target recognition failure by the nonspecific defense system: surface constituents of pathogens interfere with the alternative pathway of complement activation.

Authors: R D Horstmann
Journal: Infect Immun Date: 1992-03 Impact factor: 3.441

Review 4. Pathogenesis and pathophysiology of pneumococcal meningitis.

Authors: Barry B Mook-Kanamori; Madelijn Geldhoff; Tom van der Poll; Diederik van de Beek
Journal: Clin Microbiol Rev Date: 2011-07 Impact factor: 26.132

5. The Streptococcus pneumoniae capsule is required for full virulence in pneumococcal endophthalmitis.

Authors: Melissa E Sanders; Erin W Norcross; Zachary M Robertson; Quincy C Moore; Jonathan Fratkin; Mary E Marquart
Journal: Invest Ophthalmol Vis Sci Date: 2011-02-22 Impact factor: 4.799

6. Effect of genetic switching of capsular type on virulence of Streptococcus pneumoniae.

Authors: T Kelly; J P Dillard; J Yother
Journal: Infect Immun Date: 1994-05 Impact factor: 3.441

7. Capsular polysaccharide regulates neutrophil complement receptor interactions with type III group B streptococci.

Authors: M S Edwards; M R Wessels; C J Baker
Journal: Infect Immun Date: 1993-07 Impact factor: 3.441

8. A modified surface killing assay (MSKA) as a functional in vitro assay for identifying protective antibodies against pneumococcal surface protein A (PspA).

Authors: Kristopher R Genschmer; Mary Ann Accavitti-Loper; David E Briles
Journal: Vaccine Date: 2013-11-06 Impact factor: 3.641

9. Localization of complement component 3 on Streptococcus pneumoniae: anti-capsular antibody causes complement deposition on the pneumococcal capsule.

Authors: E J Brown; K A Joiner; R M Cole; M Berger
Journal: Infect Immun Date: 1983-01 Impact factor: 3.441

10. A quantitative analysis of the interactions of antipneumococcal antibody and complement in experimental pneumococcal bacteremia.

Authors: E J Brown; S W Hosea; C H Hammer; C G Burch; M M Frank
Journal: J Clin Invest Date: 1982-01 Impact factor: 14.808